Description: Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Home Page: www.questdiagnostics.com
500 Plaza Drive
Secaucus,
NJ
07094
United States
Phone:
973 520 2700
Officers
| Name | Title |
|---|---|
| Mr. James E. Davis | Chairman, CEO & President |
| Mr. Sam A. Samad | Executive VP & CFO |
| Mr. Michael E. Prevoznik J.D. | Senior VP & General Counsel |
| Ms. Catherine T. Doherty | Executive Vice President of Regional Businesses |
| Mr. Karthik Kuppusamy Ph.D. | Senior Vice President of Clinical Solutions |
| Mr. Michael J. Deppe | Senior VP, Corporate Controller & Chief Accounting Officer |
| Mr. Murali Balakumar | Senior VP, Chief Information & Digital Officer |
| Mr. Shawn C. Bevec | Vice President of Investor Relations |
| Ms. Kristin Lee Wallace Esq. | Senior VP & Chief Compliance Officer |
| Mr. Gary D. Samuels | Senior VP & Chief Communications Officer |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 16.0256 |
|---|---|
| Trailing PE: | 21.2304 |
| Price-to-Book MRQ: | 2.5897 |
| Price-to-Sales TTM: | 1.7645 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 50000 |